Применение лорноксикама в послеоперационном обезболивании при различных хирургических вмешательствах

1. Ревматология. Национальное руководство. Под ред. Е.Л.Насонова. М.: ГЭОТАР-Медиа, 2008. / Revmatologiia. Natsional'noe rukovodstvo. Pod red. E.L.Nasonova. M.: GEOTAR-Media, 2008. [in Russian]
2. Максимов М.Л. Современные подходы к терапии болевого синдрома. Рус. мед. журн. 2013; 34: 1734–6. / Maksimov M.L. Sovremennye podkhody k terapii bolevogo sindroma. Rus. med. zhurn. 2013; 34: 1734–6. [in Russian]
3. Каратеев А.Е. Нестероидные противовоспалительные средства при лечении боли в терапевтической практике. Справ. поликлин. врача. 2010; 4: 3–7. / Karateev A.E. Nesteroidnye protivovospalitel'nye sredstva pri lechenii boli v terapevticheskoi praktike. Sprav. poliklin. vracha. 2010; 4: 3–7. [in Russian]
4. Трухан Д.И. Выбор нестероидного противовоспалительного препарата с позиций профилактики НПВП-гастропатии и лекарственной безопасности. Consilium Medicum. 2014; 8: 14–9. / Trukhan D.I. Vybor nesteroidnogo protivovospalitel'nogo preparata s pozitsii profilaktiki NPVP-gastropatii i lekarstvennoi bezopasnosti. Consilium Medicum. 2014; 8: 14–9. [in Russian]
5. Гельфанд Б.Р., Кириенко П.А., Черниенко Л.Ю. Послеоперационная анальгезия. Рус. мед. журн. 2003; 12: 83–8. / Gel'fand B.R., Kirienko P.A., Chernienko L.Iu. Posleoperatsionnaia anal'geziia. Rus. med. zhurn. 2003; 12: 83–8. [in Russian]
6. Осипова Н.А., Абузарова Г.Р., Петрова В.В. Принципы применения анальгетических средств при острой и хронической боли. Клинические рекомендации. М.: ФГБУ «МНИОИ им. П.А.Герцена Минздравсоцразвития России», 2010. / Osipova N.A., Abuzarova G.R., Petrova V.V. Printsipy primeneniia anal'geticheskikh sredstv pri ostroi i khronicheskoi boli. Klinicheskie rekomendatsii. M.: FGBU «MNIOI im. P.A.Gertsena Minzdravsotsrazvitiia Rossii», 2010. [in Russian]
7. Бутров А.В., Кондрашенко Е.Н. Пути оптимизации послеоперационного обезболивания. РМЖ. 2012; 18. / Butrov A.V., Kondrashenko E.N. Puti optimizatsii posleoperatsionnogo obezbolivaniia. RMZh. 2012; 18. URL: http://rmj.ru/articles_8330.htm [in Rus­sian]
8. Осипова Н.А., Петрова В.В. Боль в хирургии. Средства и способы защиты. М.: МИА, 2013. / Osipova N.A., Petrova V.V. Bol' v khirurgii. Sredstva i sposoby zashchity. M.: MIA, 2013. [in Russian]
9. Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996; 51 (4): 639–57.
10. Rosenow DE, van Krieken F, Kursten FW. Intravenous administration of lornoxicam, a new NSAID, and pethidine for postoperative pain. 
A placebo-controlled pilot study. Clin Drug Invest 1996; 11 (1): 11–9.
11. Фисенко В. Ксефокам: анализ применения в Российской Федерации. Врач. 2001; 4: 42–4. / Fisenko V. Ksefokam: analiz primeneniia v Rossiiskoi Federatsii. Vrach. 2001; 4: 42–4. [in Russian]
12. Балабанова Р.М., Гришаева Т.П. Применение ксефокама (лорноксикама) для купирования острого и хронического болевого синдрома. РМЖ. 2005; 15: 1009–11. / Balabanova R.M., Grishaeva T.P. Primenenie ksefokama (lornoksikama) dlia kupirovaniia ostrogo i khronicheskogo bolevogo sindroma. RMZh. 2005; 15: 1009–11. [in Russian]
13. Балабанова Р.М. Анальгетический эффект Ксефокама при лечении болезней костно-мышечной системы. РМЖ. 2011; 10: 610–2. / Balabanova R.M. Anal'geticheskii effekt Ksefokama pri lechenii boleznei kostno-myshechnoi sistemy. RMZh. 2011; 10: 610–2. [in Russian]
14. Шевченко Е.В., Пилипович А.А., Данилов А.Б. Лорноксикам (Ксефокам) в терапии болевого синдрома. РМЖ. 2012. / Shevchenko E.V., Pilipovich A.A., Danilov A.B. Lornoksikam (Ksefokam) v terapii bolevogo sindroma. RMZh. 2012. URL: http://rmj.ru/articles_8390.htm [in Russian]
15. Сологова С.С., Илларионов А.А., Тарасов В.В. Современный анальгетик лорноксикам в лечении болевого синдрома. РМЖ. 2015; 10. / Sologova S.S., Illarionov A.A., Tarasov V.V. Sovremennyi anal'getik lornoksikam v lechenii bolevogo sindroma. RMZh. 2015; 10. URL: http://rmj.ru/articles_10149.htm [in Russian]
16. Kara I, Yavuz L, Ceylan BG, Eroǧlu F. The effect of three different lornoxicam administrations on postoperative analgesia. Agri 2008; 20 (4): 23–9.
17. Rawal N, KrØner K, Simin-Geertsen M et al. Safety of lornoxicam in the treatment of postoperative pain: a post-marketing study of analgesic regimens containing lornoxicam compared with standard analgesic treatment in 3752 day-case surgery patients. Clin Drug Investig 2010; 30 (10): 687–97.
18. Tuncer S, Yalçin N, Reisli R, Alper Y. The effects of lornoxicam in preventing remifentanil-induced postoperative hyperalgesia. Agri 2009; 21 (4): 161–7.
19. Xuerong Y, Yuguang H, Xia J, Hailan W. Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement. Anesth Analg 2008; 107 (6): 2032–7.
20. Abdelhalim AA, Al Harethy S, Moustafa M. Lornoxicam versus tramadol for post-operative pain relief in patients undergoing ENT procedures. Saudi J Anaesth 2014; 8 (1): 38–44.
21. Daabiss M, Hashish M. Effects of lornoxicam on the hemodynamic and catecholamine response to laryngoscopy and tracheal intubation. Eur J Clin Pharmacol 2011; 67 (8): 783–6.
22. Riad W, Moussa A. Lornoxicam attenuates the haemodynamic responses to laryngoscopy and tracheal intubation in the elderly. Eur 
J Anaesthesiol 2008; 25 (9): 732–6.
23. Ișik B, Arslan M, Ozsoylar O, Akçabay M. Effects of preoperative lornoxicam versus tramadol on postoperative pain and adverse effects in adult tonsillectomy patients. Agri 2009; 21 (3): 113–20.
24. Ismail SA, Mowafi HA. Preoperative peritonsillar lornoxicam infiltration is not superior to intravenous lornoxicam for pain relief following tonsillectomy in adults. Eur J Anaesthesiol 2010; 27 (9): 807–11.
25. Mowafi HA, Telmessani L, Ismail SA, Naguib MB. Preoperative lornoxicam for pain prevention after tonsillectomy in adults. J Clin Anesth 2011; 23 (2): 97–101.
26. Abdel-Ghaffar HS, Abdel-Azeem HG, Roushdy MM. Safety and efficacy of pre-incisional peritonsillar lornoxicam in paediatric post-tonsillectomy pain: a prospective double-blind, placebo-controlled, split-body clinical study. Clin Otolaryngol 2015; 40 (3): 219–26.
27. Sener M, Yilmazer C, Yilmaz I. Patient-controlled analgesia with lornoxicam vs. dipyrone for acute postoperative pain relief after septorhinoplasty: a prospective, randomized, double-blind, placebo-controlled study. Eur J Anaesthesiol 2008; 25 (3): 177–82.
28. Lu Z, Zhu Q, Fang J et al. Clinical study of analgesic effect of lornoxicam in nasal packing. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2013; 27 (20): 1145–7.
29. Das SK, Banerjee M, Mondal S. A comparative study of efficacy and safety of lornoxicam versus tramadol as analgesics after surgery on head and neck. Indian J Otolaryngol Head Neck Surg 2013; 65 (Suppl. 1): 126–30.
30. Dolmatova EV, Imaev AA, Lubnin AY. 'Scheduled' dosing of lornoxicam provides analgesia superior to that provided by 'on request' dosing following craniotomy. Eur J Anaesthesiol 2009; 26 (8): 633–7.
31. Karamanlioglu B, Turan A, Memis D et al. Infiltration with ropivacaine plus lornoxicam reduces postoperative pain and opioid consumption. Can J Anaesth 2005; 52 (10): 1047–53.
32. Arslan M, Tuncer B, Babacan A et al. Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study. Agri 2006; 18 (2): 27–33.
33. Arslan M, Ciçek R, Celep B. Comparison of the analgesic effects of intravenous paracetamol and lornoxicam in postoperative pain following thyroidectomies. Agri 2011; 23 (4): 160–6.
34. Patel A, Skelly AM, Kohn H, Preiskel HW. Double-blind placebo-controlled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patients with postoperative dental pain. Br Dent J 1991; 170 (8): 295–9.
35. NØrholt SE, Sindet-Pedersen S, Larsen U et al. Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine. Pain 1996; 67 (2–3): 335–43.
36. NØrholt SE. Treatment of acute pain following removal of mandibular third molars. Use of the dental pain model in pharmacological research and development of a comparable animal model. Int J Oral Maxillofac Surg 1998; 27 (Suppl. 1): 1–41.
37. Pektas ZO, Sener M, Bayram B et al. A comparison of pre-emptive analgesic efficacy of diflunisal and lornoxicam for postoperative pain management: a prospective, randomized, single-blind, crossover study. Int J Oral Maxillofac Surg 2007; 36 (2): 123–7.
38. MØller PL, NØrholt SE. Analgesic efficacy of quick-release versus standard lornoxicam for pain after third molar surgery: a randomized, double-blind, placebo-controlled, single-dose trial. Clin Drug Investig 2008; 28 (12): 757–66.
39. Tuzuner Oncul AM, Yazicioglu D, Alanoglu Z. Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam. Med Princ Pract 2011; 20 (5): 470–6.
40. Lustenberger FD, Grätz KW, Mutzbauer TS. Efficacy of ibuprofen versus lornoxicam after third molar surgery: a randomized, double-blind, crossover pilot study. Oral Maxillofac Surg 2011; 15 (1): 57–62.
41. Zor ZF, Isik B, Cetiner S. Efficacy of preemptive lornoxicam on postoperative analgesia after surgical removal of mandibular third molars. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117 (1): 27–31.
42. Bölükbasi N, Ersanli S, Basegmez C et al. Efficacy of quick-release lornoxicam versus placebo for acute pain management after dental implant surgery: a randomised placebo-controlled triple-blind trial. Eur J Oral Implantol 2012; 5 (2): 165–73.
43. Li C, Yang X, Ma X. Preoperative oral nonsteroidal anti-inflammatory drugs for the success of the inferior alveolar nerve block in irreversible pulpitis treatment: a systematic review and meta-analysis based on randomized controlled trials. Quintessence Int 2012; 43 (3): 209–19.
44. Prasanna N, Subbarao CV, Gutmann JL. The efficacy of pre-operative oral medication of lornoxicam and diclofenac potassium on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a double-blind, randomised controlled clinical trial. Int Endod J 2011; 44 (4): 330–6.
45. Соловьев М.М., Арьев А.Л., Арьева Г.Т. Ксефокам при одонтогенном периостите у пациентов пожилого и старческого возраста. Клин. геронтология. 2008; 7: 22–9. / Solov'ev M.M., Ar'ev A.L., Ar'eva G.T. Ksefokam pri odontogennom periostite u patsientov pozhilogo i starcheskogo vozrasta. Klin. gerontologiia. 2008; 7: 22–9. [in Russian]
46. Соловьев М.М., Арьев А.Л., Арьева Г.Т. Комплексное лечение одонтогенного периостита и возможности оценки скорости регресса воспалительного процесса в геронтостоматологии. Успехи геронтологии. 2008; 3: 439–47. / Solov'ev M.M., Ar'ev A.L., Ar'eva G.T. Kompleksnoe lechenie odontogennogo periostita i vozmozhnosti otsenki skorosti regressa vospalitel'nogo protsessa v gerontostomatologii. Uspekhi gerontologii. 2008; 3: 439–47. [in Russian]
47. Dong W, Liu RC, Liu KY et al. Comparison of antalgic effects of patient-controlled intravenous lornoxicam and sufentanil in patients after oral maxillofacial surgery. Beijing Da Xue Xue Bao 2009; 41 (1): 109–11.
48. Tsakiridis K, Zarogoulidis P, Vretzkakis G. Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass. J Thorac Dis 2014; 6 (Suppl. 1): S7–S20.
49. Daglar B, Kocoglu H, Adnan Celkan M et al. Comparison of the effects of lornoxicam versus diclofenac in pain management after cardiac surgery: A single-blind, randomized, active-controlled study. Curr Ther Res Clin Exp 2005; 66 (2): 107–16.
50. Абдрахманов В., Гапонова Н. Кардиалгии: использование нестероидного анальгетика лорноксикама на догоспитальном этапе. Врач. 2004; 1: 47–9. / Abdrakhmanov V., Gaponova N. Kardialgii: ispol'zovanie nesteroidnogo anal'getika lornoksikama na dogospital'nom etape. Vrach. 2004; 1: 47–9. [in Russian]
51. Еременко А.А., Аветисян М.И. Обезболивание в постреанимационном периоде у кардиохирургических больных. Consilium Medicum. 2007; 7: 91–5. / Eremenko A.A., Avetisian M.I. Obezbolivanie v postreanimatsionnom periode u kardiokhirurgicheskikh bol'nykh. Consilium Medicum. 2007; 7: 91–5. [in Russian]
52. Климиашвили А.Д., Веденина И.В. Болевой синдром и его лечение в хирургической клинике. РМЖ. 2013; 15. / Klimiashvili A.D., Vedenina I.V. Bolevoi sindrom i ego lechenie v khirurgicheskoi klinike. RMZh. 2013; 15. URL: http://rmj.ru/articles_8823.htm [in Russian]
53. Никода В.В., Маячкин Р.Б., Бондаренко А.В. Изучение эффективности и безопасности применения лорноксикама в раннем послеоперационном периоде. Терапевт. арх. 2007; 8. / Nikoda V.V., Maiachkin R.B., Bondarenko A.V. Izuchenie effektivnosti i bezopasnosti primeneniia lornoksikama v rannem posleoperatsionnom periode. Terapevt. arkh. 2007; 8. URL: http://medi.ru/doc/ a792203.htm [in Russian]
54. Zhao H, Ye TH, Gong ZY et al. Application of lornoxicam to patient-controlled analgesia in patients undergoing abdominal surgeries. Chin Med Sci J 2005; 20 (1): 59–62.
55. Karaman Y, Kebapci E, Gurkan A. The preemptive analgesic effect of lornoxicam in patients undergoing major abdominal surgery: a randomised controlled study. Int J Surg 2008; 6 (3): 193–6.
56. Mowafi HA, Elmakarim EA, Ismail S. Intravenous lornoxicam is more effective than paracetamol as a supplemental analgesic after lower abdominal surgery: a randomized controlled trial. World J Surg 2012; 36 (9): 2039–44.
57. Ovechkin AM, Karpov IA, Liuosev SV. Postoperative analgesia in abdominal surgery: a new look at an old problem. Anesteziol Reanimatol 2003; 5: 45–50.
58. Muslu B, Usta B, Muslu S et al. Effect of locally administered lornoxicam in the management of low back pain after lumbar epidural anesthesia: a double-blind, randomized, controlled study. Minerva Anestesiol 2009; 75 (9): 494–7.
59. Mentes O, Bagci M. Postoperative pain management after inguinal hernia repair: lornoxicam versus tramadol. Hernia 2009; 13 (4): 427–30.
60. Papadima A, Lagoudianakis EE, Antonakis PT et al. Parecoxib vs. lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial. Eur J Anaesthesiol 2007; 24 (2): 154–8.
61. Kocaayan E, Ozkardeșler S, Ozzeybek D et al. Comparison of effects of preoperatively administered lornoxicam and tenoxicam on morphine consumption after laparoscopic cholecystectomy. Eur J Anaesthesiol 2007; 24 (8): 714–9.
62. Ильканич А.Я., Поборский А.Н., Абубакиров А.С., Барбашинов Н.А. Оптимизация раннего послеоперационного обезболивания у больных хроническим геморроем. Амбулаторная хирургия. 2012; 3: 39–41. / Il'kanich A.Ia., Poborskii A.N., Abubakirov A.S., Barbashinov N.A. Optimizatsiia rannego posleoperatsionnogo obezbolivaniia u bol'nykh khronicheskim gemorroem. Ambulatornaia khirurgiia. 2012; 3: 39–41. [in Russian]
63. Kaygusuz K, Gokce G, Ozdemir Kol I et al. Efficacy of preventive analgesia with tramadol or lornoxicam for percutaneous nephrolithotomy: a prospective, randomized, double-blind, placebo-controlled study. Curr Ther Res Clin Exp 2007; 68 (4): 205–16.
64. Olmez G, Kaya S, Aflay U, Sahin H. Comparison of lornoxicam versus tramadol analgesia for transrectal prostate biopsy: a randomized prospective study. Int Urol Nephrol 2008; 40 (2): 341–4.
65. Mazaris EM, Varkarakis I, Chrisofos M et al. Use of nonsteroidal anti-inflammatory drugs after radical retropubic prostatectomy: a prospective, randomized trial. Urology 2008; 72 (6): 1293–7.
66. Memis D, Hekimoglu S, Kaya G et al. Efficacy of levobupivacaine wound infiltration with and without intravenous lornoxicam for post-varicocoele analgesia: a randomized, double-blind study. Clin Drug Investig 2008; 28 (6): 353–9.
67. Inanoglu K, Gorur S, Akkurt CO. The analgesic efficacy of preoperative versus postoperative lornoxicam in varicocele repair. J Clin Anesth 2007; 19 (8): 587–90.
68. Bilir A, Gulec S, Turgut M. Lornoxicam in extracorporeal shock-wave lithotripsy; comparison with tenoxicam and placebo in terms of analgesic consumption. Scand J Urol Nephrol 2008; 42 (2): 143–7.
69. Takmaz SA, Inan N, Goktug A et al. The analgesic effect of 8 and 16 mg lornoxicam administered before shock wave lithotripsy: a randomized, double-blind, controlled study. Urology 2008; 72 (2): 282–5.
71. Yilmaz E. Re: Takmaz SA et al. Analgesic effect of 8- and 16-mg lornoxicam administered before shock wave lithotripsy: a randomized, double-blind, controlled study (Urology 2008; 72: 282–5). Uro­logy 2009; 73 (1): 211–2.
71. Akcali GE, Iskender A, Demiraran Y et al. Randomized comparison of efficacy of paracetamol, lornoxicam, and tramadol representing three different groups of analgesics for pain control in extracorporeal shockwave lithotripsy. J Endourol 2010; 24 (4): 615–20.
72. Ozkan F, Erdemir F, Erkorkmaz U. Comparison of three different analgesic protocols during shockwave lithotripsy. J Endourol 2012; 26 (6): 691–6.
73. Trampitsch E, Pipam W, Moertl M et al. Preemptive randomized, double-blind study with lornoxicam in gynecological surgery. Schmerz 2003; 17 (1): 4–10.
74. Karaca M, Kocoglu H, Gocmen A. Comparison of lornoxicam with tramadol in patient-controlled analgesia after gynecological surgery. Eur J Gynaecol Oncol 2006; 27 (1): 78–80.
75. Kemal SO, Sahin S, Apan A. Comparison of tramadol, tramadol-metamizol and tramadol-lornoxicam administered by intravenous PCA in management of postoperative pain. Agri 2007; 19 (4): 24–31.
76. Николайко Д.А., Кычакова Ф.Д., Яковлева Т.С. и др. Ксефокам в комплексе анестезиологического пособия и послеоперационного обезболивания у пациентов гинекологического профиля. Здравоохранение Дальнего Востока. 2010; 1: 85–8. / Nikolaiko D.A., Kychakova F.D., Iakovleva T.S. i dr. Ksefokam v komplekse anesteziologicheskogo posobiia i posleoperatsionnogo obezbolivaniia u patsientov ginekologicheskogo profilia. Zdravookhranenie Dal'nego Vostoka. 2010; 1: 85–8. [in Russian]
77. Hein A, Norlander C, Blom L, Jakobsson J. Is pain prophylaxis in minor gynaecological surgery of clinical value? A double-blind placebo controlled study of paracetamol 1 g versus lornoxicam 8 mg given orally. Ambul Surg 2001; 9 (2): 91–4.
78. Erdoǧan I, Cakan T, Ozcan A et al. Effect of lornoxicam on postoperative analgesia after myomectomy. Agri 2008; 20 (1): 26–31.
79. Ilias W, Jansen M. Pain control after hysterectomy: an observer-blind, randomised trial of lornoxicam versus tramadol. Br J Clin Pract 1996; 50 (4): 197–202.
80. Gong ZY, Ye TH, Qin XT et al. Patient-controlled analgesia with lornoxicam in patients undergoing gynecological surgery. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2001; 23 (5): 472–5.
81. Visalyaputra S, Sanansilp V, Pechpaisit N et al. Postoperative analgesic effects of intravenous lornoxicam and morphine with pre-emtiveropivacaine skin infiltration and preperitoneal instillation after transabdominal hysterectomy. J Med Assoc Thai 2002; 85 (Suppl. 3): S1010–6.
82. Karaman S, Gunusen I, Uyar M, Firat V. The effect of pre-operative lornoxicam and ketoprofen application on the morphine consumption of post-operative patient-controlled analgesia. J Int Med Res 2006; 34 (2): 168–75.
83. Sapolya O, Karamanhoglu B, Memis D. Analgesic effects of lornoxicam after total abdominal hysterectomy. J Opioid Manag 2007; 3 (3): 155–9.
84. Jiao H, Ren F. Pretreatment with lornoxicam, a cyclooxygenase inhibitor, relieves postoperative immuno-suppression after total abdominal hysterectomy. Tohoku J Exp Med 2009; 219 (4): 289–94.
85. Tang QF, Qian YN, Qiu YH et al. Effects of preemptive intravenous lornoxicam on the analgesic efficacy of epidural morphine and expression of chemokines in women undergoing hysterectomy. Curr Ther Res Clin Exp 2009; 70 (1): 1–9.
86. Jiao HN, Ren F, Cai HW. Effect of intravenous lornoxicam at different doses on the immune function in patients undergoing total abdominal hysterectomy. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30 (8): 1844–6.
87. Zhao H, Ye TH, Gong ZY. Non-inferiority study of lornoxicam to patient-controlled analgesia in patients after hysterectomy. Beijing Da Xue Xue Bao 2013; 45 (1): 119–22.
88. Staunstrup H, Ovesen J, Larsen UT et al. Efficacy and tolerability of lornoxicam versus tramadol in postoperative pain. J Clin Pharmacol 1999; 39 (8): 834–41.
89. Inan N, Ozcan N, Takmaz SA et al. Efficacy of lornoxicam in postoperative analgesia after total knee replacement surgery. Agri 2007; 
19 (2): 38–45.
90. Koltka K, Koknel-Talu G, Asik M, Ozyalcin S. Comparison of efficacy of intraarticular application of magnesium, levobupivacaine and lornoxicam with placebo in arthroscopic surgery. Knee Surg Sports Traumatol Arthrosc 2011; 19 (11): 1884–9.
91. Amin S, Yosry M, El DI. The effect of the addition of lornoxicam (xefocam) intrarticularly on the WOMAC Scale in patients undergoing arthroscopic anterior cruciate ligament reconstruction. Middle East J Anaesthesiol 2011; 21 (1): 15–21.
92. Sivrikoz N, Koltka K, Güresti E et al. Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study. Agri 2014; 26 (1): 23–8.
93. Sen S, Ugur B, Aydin ON et al. The analgesic effect of lornoxicam when added to lidocaine for intravenous regional anaesthesia. Br J Anaesth 2006; 97 (3): 408–13.
94. Sertoz N, Kocaoglu N, Ayanoǧlu Hö. Comparison of lornoxicam and fentanyl when added to lidocaine in intravenous regional anesthesia. Braz J Anesthesiol 2013; 63 (4): 311–6.
95. Kol IO, Ozturk H, Kaygusuz K et al. Addition of dexmedetomidine or lornoxicam to prilocaine in intravenous regional anaesthesia for hand or forearm surgery: a randomized controlled study. Clin Drug Investig 2009; 29 (2): 121–9.
96. Осипова Н.А. Неопиоидные анальгетики в системе защиты пациентов от боли в хирургии. Consilium Medicum. Хирургия (Прил.). 2005; 2: 22–4. / Osipova N.A. Neopioidnye anal'getiki v sisteme zashchity patsientov ot boli v khirurgii. Consilium Medicum. Surgery (Suppl.). 2005; 2: 22–4. [in Russian]
97. Петрова В.В., Осипова Н.А., Береснев В.П., Долгополова Т.В. Лорноксикам (ксефокам) как средство профилактики и лечения послеоперационного БС среди других НПВП. Анестезиология и реаниматология. 2005; 5: 39–44. / Petrova V.V., Osipova N.A., Beresnev V.P., Dolgopolova T.V. Lornoksikam (ksefokam) kak sredstvo profilaktiki i lecheniia posleoperatsionnogo BS sredi drugikh NPVP. Anesteziologiia i reanimatologiia. 2005; 5: 39–44. [in Russian]
98. Осипова Н.А., Петрова В.В., Ермолаев П.М., Береснев В.А. Нестероидные противовоспалительные препараты в лечении послеоперационной боли у онкологических больных. Фарматека. 2006; 6: 74–8. / Osipova N.A., Petrova V.V., Ermolaev P.M., Beresnev V.A. Nesteroidnye protivovospalitel'nye preparaty v lechenii posleoperatsionnoi boli u onkologicheskikh bol'nykh. Farmateka. 2006; 6: 74–8. [in Russian]
99. Lin SQ, Wu XJ, Zheng S et al. A comparison of the metabolic effect of postoperative analgesia with lornoxicam and morphine or morphine on patients undergoing gastrointestinal carcinoma operation .Zhonghua Wei Chang Wai Ke Za Zhi 2008; 11 (2): 141–4.
100. Koyuncu T, Oǧuz G, Akben S et al. The effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients undergoing modified radical mastectomy. Agri 2013; 25 (4): 169–78.
101. Sun HL, Dong YC, Wang CQ et al. Effects of postoperative analgesia with the combination of tramadol and lornoxicam on serum inflammatory cytokines in patients with gastric cancer. Int J Clin Pharmacol Ther 2014; 52 (12): 1023–9.
102. Forget P, De Kock M. Perspectives in anaesthesia for cancer surgery. J Cancer Res Clin Oncol 2014; 140 (3): 353–9.
103. Трухан Д.И., Деговцов Е.Н. Выбор анальгетика в хирургической практике: внимание на кеторолак. Consilium Medicum. Хирургия (Прил.). 2014; 2: 51–4. / Trukhan D.I., Degovtsov E.N. Vybor anal'getika v khirurgicheskoi praktike: vnimanie na ketorolak. Consilium Medicum. Surgery (Suppl.). 2014; 2: 51–4. [in Russian]
104. Новиков Г.А., Прохоров Б.М., Вайсман М.А., Рудой С.В. Возможности нестероидного противовоспалительного анальгетика ксефокама в терапии хронической боли онкологического генеза. Паллиативная медицина и реабилитация. 2004; 1: 11–4. / Novikov G.A., Prokhorov B.M., Vaisman M.A., Rudoi S.V. Vozmozhnosti nesteroidnogo protivovospalitel'nogo anal'getika ksefokama v terapii khronicheskoi boli onkologicheskogo geneza. Palliativnaia meditsina i reabilitatsiia. 2004; 1: 11–4. [in Russian]
105. Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996; 51 (4): 639–57.
106. Верткин А., Тополянский А., Гирель О. Сравнительная эффективность и безопасность ксефокама и анальгина на догоспитальном этапе. Врач. 2004; 9: 52–5. / Vertkin A., Topolianskii A., Girel' O. Sravnitel'naia effektivnost' i bezopasnost' ksefokama i anal'gina na dogospital'nom etape. Vrach. 2004; 9: 52–5. [in Russian]
107. Носков С., Козлова О., Башкина А., Фетелего О. Эпидуральное введение ксефокама при хронической дискогенной боли в нижней части спины. Врач. 2013; 5: 71–5. / Noskov S., Kozlova O., Bashkina A., Fetelego O. Epidural'noe vvedenie ksefokama pri khronicheskoi diskogennoi boli v nizhnei chasti spiny. Vrach. 2013; 5: 71–5. [in Russian]
108. Аникин С.Г., Алексеева Л.И. Применение ксефокама (лорноксикама) у больных остеоартрозом. Фарматека. 2013; 7: 74–7. / Anikin S.G., Alekseeva L.I. Primenenie ksefokama (lornoksikama) u bol'nykh osteoartrozom. Farmateka. 2013; 7: 74–7. [in Russian]
109. Трухан Д.И., Филимонов С.Н., Викторова И.А. Клиника, диагностика и лечение основных ревматических заболеваний. СПб.: СпецЛит, 2014. / Trukhan D.I., Filimonov S.N., Viktorova I.A. Klinika, diagnostika i lechenie osnovnykh revmaticheskikh zabolevanii. SPb.: SpetsLit, 2014. [in Russian]

________________________________________________

1. Revmatologiia. Natsional'noe rukovodstvo. Pod red. E.L.Nasonova. M.: GEOTAR-Media, 2008. [in Russian]
2. Maksimov M.L. Sovremennye podkhody k terapii bolevogo sindroma. Rus. med. zhurn. 2013; 34: 1734–6. [in Russian]
3. Karateev A.E. Nesteroidnye protivovospalitel'nye sredstva pri lechenii boli v terapevticheskoi praktike. Sprav. poliklin. vracha. 2010; 4: 3–7. [in Russian]
4. Trukhan D.I. Vybor nesteroidnogo protivovospalitel'nogo preparata s pozitsii profilaktiki NPVP-gastropatii i lekarstvennoi bezopasnosti. Consilium Medicum. 2014; 8: 14–9. [in Russian]
5. Gel'fand B.R., Kirienko P.A., Chernienko L.Iu. Posleoperatsionnaia anal'geziia. Rus. med. zhurn. 2003; 12: 83–8. [in Russian]
6. Osipova N.A., Abuzarova G.R., Petrova V.V. Printsipy primeneniia anal'geticheskikh sredstv pri ostroi i khronicheskoi boli. Klinicheskie rekomendatsii. M.: FGBU «MNIOI im. P.A.Gertsena Minzdravsotsrazvitiia Rossii», 2010. [in Russian]
7. Butrov A.V., Kondrashenko E.N. Puti optimizatsii posleoperatsionnogo obezbolivaniia. RMZh. 2012; 18. URL: http://rmj.ru/articles_8330.htm [in Rus­sian]
8. Osipova N.A., Petrova V.V. Bol' v khirurgii. Sredstva i sposoby zashchity. M.: MIA, 2013. [in Russian]
9. Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996; 51 (4): 639–57.
10. Rosenow DE, van Krieken F, Kursten FW. Intravenous administration of lornoxicam, a new NSAID, and pethidine for postoperative pain. 
A placebo-controlled pilot study. Clin Drug Invest 1996; 11 (1): 11–9.
11. Fisenko V. Ksefokam: analiz primeneniia v Rossiiskoi Federatsii. Vrach. 2001; 4: 42–4. [in Russian]
12. Balabanova R.M., Grishaeva T.P. Primenenie ksefokama (lornoksikama) dlia kupirovaniia ostrogo i khronicheskogo bolevogo sindroma. RMZh. 2005; 15: 1009–11. [in Russian]
13. Balabanova R.M. Anal'geticheskii effekt Ksefokama pri lechenii boleznei kostno-myshechnoi sistemy. RMZh. 2011; 10: 610–2. [in Russian]
14. Shevchenko E.V., Pilipovich A.A., Danilov A.B. Lornoksikam (Ksefokam) v terapii bolevogo sindroma. RMZh. 2012. URL: http://rmj.ru/articles_8390.htm [in Russian]
15. Sologova S.S., Illarionov A.A., Tarasov V.V. Sovremennyi anal'getik lornoksikam v lechenii bolevogo sindroma. RMZh. 2015; 10. URL: http://rmj.ru/articles_10149.htm [in Russian]
16. Kara I, Yavuz L, Ceylan BG, Eroǧlu F. The effect of three different lornoxicam administrations on postoperative analgesia. Agri 2008; 20 (4): 23–9.
17. Rawal N, KrØner K, Simin-Geertsen M et al. Safety of lornoxicam in the treatment of postoperative pain: a post-marketing study of analgesic regimens containing lornoxicam compared with standard analgesic treatment in 3752 day-case surgery patients. Clin Drug Investig 2010; 30 (10): 687–97.
18. Tuncer S, Yalçin N, Reisli R, Alper Y. The effects of lornoxicam in preventing remifentanil-induced postoperative hyperalgesia. Agri 2009; 21 (4): 161–7.
19. Xuerong Y, Yuguang H, Xia J, Hailan W. Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement. Anesth Analg 2008; 107 (6): 2032–7.
20. Abdelhalim AA, Al Harethy S, Moustafa M. Lornoxicam versus tramadol for post-operative pain relief in patients undergoing ENT procedures. Saudi J Anaesth 2014; 8 (1): 38–44.
21. Daabiss M, Hashish M. Effects of lornoxicam on the hemodynamic and catecholamine response to laryngoscopy and tracheal intubation. Eur J Clin Pharmacol 2011; 67 (8): 783–6.
22. Riad W, Moussa A. Lornoxicam attenuates the haemodynamic responses to laryngoscopy and tracheal intubation in the elderly. Eur J Anaesthesiol 2008; 25 (9): 732–6.
23. Ișik B, Arslan M, Ozsoylar O, Akçabay M. Effects of preoperative lornoxicam versus tramadol on postoperative pain and adverse effects in adult tonsillectomy patients. Agri 2009; 21 (3): 113–20.
24. Ismail SA, Mowafi HA. Preoperative peritonsillar lornoxicam infiltration is not superior to intravenous lornoxicam for pain relief following tonsillectomy in adults. Eur J Anaesthesiol 2010; 27 (9): 807–11.
25. Mowafi HA, Telmessani L, Ismail SA, Naguib MB. Preoperative lornoxicam for pain prevention after tonsillectomy in adults. J Clin Anesth 2011; 23 (2): 97–101.
26. Abdel-Ghaffar HS, Abdel-Azeem HG, Roushdy MM. Safety and efficacy of pre-incisional peritonsillar lornoxicam in paediatric post-tonsillectomy pain: a prospective double-blind, placebo-controlled, split-body clinical study. Clin Otolaryngol 2015; 40 (3): 219–26.
27. Sener M, Yilmazer C, Yilmaz I. Patient-controlled analgesia with lornoxicam vs. dipyrone for acute postoperative pain relief after septorhinoplasty: a prospective, randomized, double-blind, placebo-controlled study. Eur J Anaesthesiol 2008; 25 (3): 177–82.
28. Lu Z, Zhu Q, Fang J et al. Clinical study of analgesic effect of lornoxicam in nasal packing. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2013; 27 (20): 1145–7.
29. Das SK, Banerjee M, Mondal S. A comparative study of efficacy and safety of lornoxicam versus tramadol as analgesics after surgery on head and neck. Indian J Otolaryngol Head Neck Surg 2013; 65 (Suppl. 1): 126–30.
30. Dolmatova EV, Imaev AA, Lubnin AY. 'Scheduled' dosing of lornoxicam provides analgesia superior to that provided by 'on request' dosing following craniotomy. Eur J Anaesthesiol 2009; 26 (8): 633–7.
31. Karamanlioglu B, Turan A, Memis D et al. Infiltration with ropivacaine plus lornoxicam reduces postoperative pain and opioid consumption. Can J Anaesth 2005; 52 (10): 1047–53.
32. Arslan M, Tuncer B, Babacan A et al. Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study. Agri 2006; 18 (2): 27–33.
33. Arslan M, Ciçek R, Celep B. Comparison of the analgesic effects of intravenous paracetamol and lornoxicam in postoperative pain following thyroidectomies. Agri 2011; 23 (4): 160–6.
34. Patel A, Skelly AM, Kohn H, Preiskel HW. Double-blind placebo-controlled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patients with postoperative dental pain. Br Dent J 1991; 170 (8): 295–9.
35. NØrholt SE, Sindet-Pedersen S, Larsen U et al. Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine. Pain 1996; 67 (2–3): 335–43.
36. NØrholt SE. Treatment of acute pain following removal of mandibular third molars. Use of the dental pain model in pharmacological research and development of a comparable animal model. Int J Oral Maxillofac Surg 1998; 27 (Suppl. 1): 1–41.
37. Pektas ZO, Sener M, Bayram B et al. A comparison of pre-emptive analgesic efficacy of diflunisal and lornoxicam for postoperative pain management: a prospective, randomized, single-blind, crossover study. Int J Oral Maxillofac Surg 2007; 36 (2): 123–7.
38. MØller PL, NØrholt SE. Analgesic efficacy of quick-release versus standard lornoxicam for pain after third molar surgery: a randomized, double-blind, placebo-controlled, single-dose trial. Clin Drug Investig 2008; 28 (12): 757–66.
39. Tuzuner Oncul AM, Yazicioglu D, Alanoglu Z. Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam. Med Princ Pract 2011; 20 (5): 470–6.
40. Lustenberger FD, Grätz KW, Mutzbauer TS. Efficacy of ibuprofen versus lornoxicam after third molar surgery: a randomized, double-blind, crossover pilot study. Oral Maxillofac Surg 2011; 15 (1): 57–62.
41. Zor ZF, Isik B, Cetiner S. Efficacy of preemptive lornoxicam on postoperative analgesia after surgical removal of mandibular third molars. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117 (1): 27–31.
42. Bölükbasi N, Ersanli S, Basegmez C et al. Efficacy of quick-release lornoxicam versus placebo for acute pain management after dental implant surgery: a randomised placebo-controlled triple-blind trial. Eur J Oral Implantol 2012; 5 (2): 165–73.
43. Li C, Yang X, Ma X. Preoperative oral nonsteroidal anti-inflammatory drugs for the success of the inferior alveolar nerve block in irreversible pulpitis treatment: a systematic review and meta-analysis based on randomized controlled trials. Quintessence Int 2012; 43 (3): 209–19.
44. Prasanna N, Subbarao CV, Gutmann JL. The efficacy of pre-operative oral medication of lornoxicam and diclofenac potassium on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a double-blind, randomised controlled clinical trial. Int Endod J 2011; 44 (4): 330–6.
45. Solov'ev M.M., Ar'ev A.L., Ar'eva G.T. Ksefokam pri odontogennom periostite u patsientov pozhilogo i starcheskogo vozrasta. Klin. gerontologiia. 2008; 7: 22–9. [in Russian]
46. Solov'ev M.M., Ar'ev A.L., Ar'eva G.T. Kompleksnoe lechenie odontogennogo periostita i vozmozhnosti otsenki skorosti regressa vospalitel'nogo protsessa v gerontostomatologii. Uspekhi gerontologii. 2008; 3: 439–47. [in Russian]
47. Dong W, Liu RC, Liu KY et al. Comparison of antalgic effects of patient-controlled intravenous lornoxicam and sufentanil in patients after oral maxillofacial surgery. Beijing Da Xue Xue Bao 2009; 41 (1): 109–11.
48. Tsakiridis K, Zarogoulidis P, Vretzkakis G. Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass. J Thorac Dis 2014; 6 (Suppl. 1): S7–S20.
49. Daglar B, Kocoglu H, Adnan Celkan M et al. Comparison of the effects of lornoxicam versus diclofenac in pain management after cardiac surgery: A single-blind, randomized, active-controlled study. Curr Ther Res Clin Exp 2005; 66 (2): 107–16.
50. Abdrakhmanov V., Gaponova N. Kardialgii: ispol'zovanie nesteroidnogo anal'getika lornoksikama na dogospital'nom etape. Vrach. 2004; 1: 47–9. [in Russian]
51. Eremenko A.A., Avetisian M.I. Obezbolivanie v postreanimatsionnom periode u kardiokhirurgicheskikh bol'nykh. Consilium Medicum. 2007; 7: 91–5. [in Russian]
52. Klimiashvili A.D., Vedenina I.V. Bolevoi sindrom i ego lechenie v khirurgicheskoi klinike. RMZh. 2013; 15. URL: http://rmj.ru/articles_8823.htm [in Russian]
53. Nikoda V.V., Maiachkin R.B., Bondarenko A.V. Izuchenie effektivnosti i bezopasnosti primeneniia lornoksikama v rannem posleoperatsionnom periode. Terapevt. arkh. 2007; 8. URL: http://medi.ru/doc/ a792203.htm [in Russian]
54. Zhao H, Ye TH, Gong ZY et al. Application of lornoxicam to patient-controlled analgesia in patients undergoing abdominal surgeries. Chin Med Sci J 2005; 20 (1): 59–62.
55. Karaman Y, Kebapci E, Gurkan A. The preemptive analgesic effect of lornoxicam in patients undergoing major abdominal surgery: a randomised controlled study. Int J Surg 2008; 6 (3): 193–6.
56. Mowafi HA, Elmakarim EA, Ismail S. Intravenous lornoxicam is more effective than paracetamol as a supplemental analgesic after lower abdominal surgery: a randomized controlled trial. World J Surg 2012; 36 (9): 2039–44.
57. Ovechkin AM, Karpov IA, Liuosev SV. Postoperative analgesia in abdominal surgery: a new look at an old problem. Anesteziol Reanimatol 2003; 5: 45–50.
58. Muslu B, Usta B, Muslu S et al. Effect of locally administered lornoxicam in the management of low back pain after lumbar epidural anesthesia: a double-blind, randomized, controlled study. Minerva Anestesiol 2009; 75 (9): 494–7.
59. Mentes O, Bagci M. Postoperative pain management after inguinal hernia repair: lornoxicam versus tramadol. Hernia 2009; 13 (4): 427–30.
60. Papadima A, Lagoudianakis EE, Antonakis PT et al. Parecoxib vs. lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial. Eur J Anaesthesiol 2007; 24 (2): 154–8.
61. Kocaayan E, Ozkardeșler S, Ozzeybek D et al. Comparison of effects of preoperatively administered lornoxicam and tenoxicam on morphine consumption after laparoscopic cholecystectomy. Eur J Anaesthesiol 2007; 24 (8): 714–9.
62. Il'kanich A.Ia., Poborskii A.N., Abubakirov A.S., Barbashinov N.A. Optimizatsiia rannego posleoperatsionnogo obezbolivaniia u bol'nykh khronicheskim gemorroem. Ambulatornaia khirurgiia. 2012; 3: 39–41. [in Russian]
63. Kaygusuz K, Gokce G, Ozdemir Kol I et al. Efficacy of preventive analgesia with tramadol or lornoxicam for percutaneous nephrolithotomy: a prospective, randomized, double-blind, placebo-controlled study. Curr Ther Res Clin Exp 2007; 68 (4): 205–16.
64. Olmez G, Kaya S, Aflay U, Sahin H. Comparison of lornoxicam versus tramadol analgesia for transrectal prostate biopsy: a randomized prospective study. Int Urol Nephrol 2008; 40 (2): 341–4.
65. Mazaris EM, Varkarakis I, Chrisofos M et al. Use of nonsteroidal anti-inflammatory drugs after radical retropubic prostatectomy: a prospective, randomized trial. Urology 2008; 72 (6): 1293–7.
66. Memis D, Hekimoglu S, Kaya G et al. Efficacy of levobupivacaine wound infiltration with and without intravenous lornoxicam for post-varicocoele analgesia: a randomized, double-blind study. Clin Drug Investig 2008; 28 (6): 353–9.
67. Inanoglu K, Gorur S, Akkurt CO. The analgesic efficacy of preoperative versus postoperative lornoxicam in varicocele repair. J Clin Anesth 2007; 19 (8): 587–90.
68. Bilir A, Gulec S, Turgut M. Lornoxicam in extracorporeal shock-wave lithotripsy; comparison with tenoxicam and placebo in terms of analgesic consumption. Scand J Urol Nephrol 2008; 42 (2): 143–7.
69. Takmaz SA, Inan N, Goktug A et al. The analgesic effect of 8 and 16 mg lornoxicam administered before shock wave lithotripsy: a randomized, double-blind, controlled study. Urology 2008; 72 (2): 282–5.
71. Yilmaz E. Re: Takmaz SA et al. Analgesic effect of 8- and 16-mg lornoxicam administered before shock wave lithotripsy: a randomized, double-blind, controlled study (Urology 2008; 72: 282–5). Uro­logy 2009; 73 (1): 211–2.
71. Akcali GE, Iskender A, Demiraran Y et al. Randomized comparison of efficacy of paracetamol, lornoxicam, and tramadol representing three different groups of analgesics for pain control in extracorporeal shockwave lithotripsy. J Endourol 2010; 24 (4): 615–20.
72. Ozkan F, Erdemir F, Erkorkmaz U. Comparison of three different analgesic protocols during shockwave lithotripsy. J Endourol 2012; 26 (6): 691–6.
73. Trampitsch E, Pipam W, Moertl M et al. Preemptive randomized, double-blind study with lornoxicam in gynecological surgery. Schmerz 2003; 17 (1): 4–10.
74. Karaca M, Kocoglu H, Gocmen A. Comparison of lornoxicam with tramadol in patient-controlled analgesia after gynecological surgery. Eur J Gynaecol Oncol 2006; 27 (1): 78–80.
75. Kemal SO, Sahin S, Apan A. Comparison of tramadol, tramadol-metamizol and tramadol-lornoxicam administered by intravenous PCA in management of postoperative pain. Agri 2007; 19 (4): 24–31.
76. Nikolaiko D.A., Kychakova F.D., Iakovleva T.S. i dr. Ksefokam v komplekse anesteziologicheskogo posobiia i posleoperatsionnogo obezbolivaniia u patsientov ginekologicheskogo profilia. Zdravookhranenie Dal'nego Vostoka. 2010; 1: 85–8. [in Russian]
77. Hein A, Norlander C, Blom L, Jakobsson J. Is pain prophylaxis in minor gynaecological surgery of clinical value? A double-blind placebo controlled study of paracetamol 1 g versus lornoxicam 8 mg given orally. Ambul Surg 2001; 9 (2): 91–4.
78. Erdoǧan I, Cakan T, Ozcan A et al. Effect of lornoxicam on postoperative analgesia after myomectomy. Agri 2008; 20 (1): 26–31.
79. Ilias W, Jansen M. Pain control after hysterectomy: an observer-blind, randomised trial of lornoxicam versus tramadol. Br J Clin Pract 1996; 50 (4): 197–202.
80. Gong ZY, Ye TH, Qin XT et al. Patient-controlled analgesia with lornoxicam in patients undergoing gynecological surgery. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2001; 23 (5): 472–5.
81. Visalyaputra S, Sanansilp V, Pechpaisit N et al. Postoperative analgesic effects of intravenous lornoxicam and morphine with pre-emtiveropivacaine skin infiltration and preperitoneal instillation after transabdominal hysterectomy. J Med Assoc Thai 2002; 85 (Suppl. 3): S1010–6.
82. Karaman S, Gunusen I, Uyar M, Firat V. The effect of pre-operative lornoxicam and ketoprofen application on the morphine consumption of post-operative patient-controlled analgesia. J Int Med Res 2006; 34 (2): 168–75.
83. Sapolya O, Karamanhoglu B, Memis D. Analgesic effects of lornoxicam after total abdominal hysterectomy. J Opioid Manag 2007; 3 (3): 155–9.
84. Jiao H, Ren F. Pretreatment with lornoxicam, a cyclooxygenase inhibitor, relieves postoperative immuno-suppression after total abdominal hysterectomy. Tohoku J Exp Med 2009; 219 (4): 289–94.
85. Tang QF, Qian YN, Qiu YH et al. Effects of preemptive intravenous lornoxicam on the analgesic efficacy of epidural morphine and expression of chemokines in women undergoing hysterectomy. Curr Ther Res Clin Exp 2009; 70 (1): 1–9.
86. Jiao HN, Ren F, Cai HW. Effect of intravenous lornoxicam at different doses on the immune function in patients undergoing total abdominal hysterectomy. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30 (8): 1844–6.
87. Zhao H, Ye TH, Gong ZY. Non-inferiority study of lornoxicam to patient-controlled analgesia in patients after hysterectomy. Beijing Da Xue Xue Bao 2013; 45 (1): 119–22.
88. Staunstrup H, Ovesen J, Larsen UT et al. Efficacy and tolerability of lornoxicam versus tramadol in postoperative pain. J Clin Pharmacol 1999; 39 (8): 834–41.
89. Inan N, Ozcan N, Takmaz SA et al. Efficacy of lornoxicam in postoperative analgesia after total knee replacement surgery. Agri 2007; 
19 (2): 38–45.
90. Koltka K, Koknel-Talu G, Asik M, Ozyalcin S. Comparison of efficacy of intraarticular application of magnesium, levobupivacaine and lornoxicam with placebo in arthroscopic surgery. Knee Surg Sports Traumatol Arthrosc 2011; 19 (11): 1884–9.
91. Amin S, Yosry M, El DI. The effect of the addition of lornoxicam (xefocam) intrarticularly on the WOMAC Scale in patients undergoing arthroscopic anterior cruciate ligament reconstruction. Middle East J Anaesthesiol 2011; 21 (1): 15–21.
92. Sivrikoz N, Koltka K, Güresti E et al. Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study. Agri 2014; 26 (1): 23–8.
93. Sen S, Ugur B, Aydin ON et al. The analgesic effect of lornoxicam when added to lidocaine for intravenous regional anaesthesia. Br J Anaesth 2006; 97 (3): 408–13.
94. Sertoz N, Kocaoglu N, Ayanoǧlu Hö. Comparison of lornoxicam and fentanyl when added to lidocaine in intravenous regional anesthesia. Braz J Anesthesiol 2013; 63 (4): 311–6.
95. Kol IO, Ozturk H, Kaygusuz K et al. Addition of dexmedetomidine or lornoxicam to prilocaine in intravenous regional anaesthesia for hand or forearm surgery: a randomized controlled study. Clin Drug Investig 2009; 29 (2): 121–9.
96. Osipova N.A. Neopioidnye anal'getiki v sisteme zashchity patsientov ot boli v khirurgii. Consilium Medicum. Surgery (Suppl.). 2005; 2: 22–4. [in Russian]
97. Petrova V.V., Osipova N.A., Beresnev V.P., Dolgopolova T.V. Lornoksikam (ksefokam) kak sredstvo profilaktiki i lecheniia posleoperatsionnogo BS sredi drugikh NPVP. Anesteziologiia i reanimatologiia. 2005; 5: 39–44. [in Russian]
98. Osipova N.A., Petrova V.V., Ermolaev P.M., Beresnev V.A. Nesteroidnye protivovospalitel'nye preparaty v lechenii posleoperatsionnoi boli u onkologicheskikh bol'nykh. Farmateka. 2006; 6: 74–8. [in Russian]
99. Lin SQ, Wu XJ, Zheng S et al. A comparison of the metabolic effect of postoperative analgesia with lornoxicam and morphine or morphine on patients undergoing gastrointestinal carcinoma operation .Zhonghua Wei Chang Wai Ke Za Zhi 2008; 11 (2): 141–4.
100. Koyuncu T, Oǧuz G, Akben S et al. The effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients undergoing modified radical mastectomy. Agri 2013; 25 (4): 169–78.
101. Sun HL, Dong YC, Wang CQ et al. Effects of postoperative analgesia with the combination of tramadol and lornoxicam on serum inflammatory cytokines in patients with gastric cancer. Int J Clin Pharmacol Ther 2014; 52 (12): 1023–9.
102. Forget P, De Kock M. Perspectives in anaesthesia for cancer surgery. J Cancer Res Clin Oncol 2014; 140 (3): 353–9.
103. Trukhan D.I., Degovtsov E.N. Vybor anal'getika v khirurgicheskoi praktike: vnimanie na ketorolak. Consilium Medicum. Surgery (Suppl.). 2014; 2: 51–4. [in Russian]
104. Novikov G.A., Prokhorov B.M., Vaisman M.A., Rudoi S.V. Vozmozhnosti nesteroidnogo protivovospalitel'nogo anal'getika ksefokama v terapii khronicheskoi boli onkologicheskogo geneza. Palliativnaia meditsina i reabilitatsiia. 2004; 1: 11–4. [in Russian]
105. Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996; 51 (4): 639–57.
106. Vertkin A., Topolianskii A., Girel' O. Sravnitel'naia effektivnost' i bezopasnost' ksefokama i anal'gina na dogospital'nom etape. Vrach. 2004; 9: 52–5. [in Russian]
107. Noskov S., Kozlova O., Bashkina A., Fetelego O. Epidural'noe vvedenie ksefokama pri khronicheskoi diskogennoi boli v nizhnei chasti spiny. Vrach. 2013; 5: 71–5. [in Russian]
108. Anikin S.G., Alekseeva L.I. Primenenie ksefokama (lornoksikama) u bol'nykh osteoartrozom. Farmateka. 2013; 7: 74–7. [in Russian]
109. Trukhan D.I., Filimonov S.N., Viktorova I.A. Klinika, diagnostika i lechenie osnovnykh revmaticheskikh zabolevanii. SPb.: SpetsLit, 2014. [in Russian]

Д.Г.Макушин*1,2, Д.И.Трухан1

1 ГБОУ ВПО Омский государственный медицинский университет Минздрава России. 644043, Россия, Омск, ул. Ленина, д. 12;
2 ФГБУЗ Западно-Сибирский медицинский центр ФМБА России. 644033, Россия, Омск, ул. Красный Путь, д. 127, к. 1
*dmg1@mail.ru

________________________________________________

D.G.Makushin*1,2, D.I.Trukhan1

1 Omsk State Medical University of the Ministry of Health of the Russian Federation. 644043, Russian Federation, Omsk, ul. Lenina, d. 12;
2 West Siberian Medical Center. 644033, Russian Federation, Omsk, ul. Krasnyi Put', d. 127, k. 1
*dmg1@mail.ru